Patents by Inventor Mark Wingertzahn

Mark Wingertzahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligosaccharide compositions and methods of use thereof for treating viral infections
    Patent number: 12661366
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for treating respiratory viral illnesses, such as COVID-19.
    Type: Grant
    Filed: April 29, 2021
    Date of Patent: June 23, 2026
    Assignee: DSM Nutritional Products, LLC
    Inventors: Jonathan Lawrence, Jeffrey Meisner, Christopher Matthew Liu, Madeline Rosini, Max Hecht, Mark Wingertzahn, Geoffrey A. von Maltzahn
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20250345351
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for decreasing inflammation for the treatment of inflammatory and immune disorders and diseases.
    Type: Application
    Filed: September 24, 2021
    Publication date: November 13, 2025
    Applicant: DSM Nutritional Products, LLC
    Inventors: Jeffrey MEISNER, Christopher Matthew LIU, Madeline ROSINI, Max HECHT, Eric HUMPHRIES, Adarsh JOSE, Johan VAN HYLCKAMA VLIEG, Mark DOWLING, Mark WINGERTZAHN, Jackson LEE
  • Compositions and Methods For Treating Neurological Conditions
    Publication number: 20240050454
    Abstract: As described below, the present disclosure features compositions containing a cannabidiol (CBD) and/or psilocybin, optionally in combination with a mushroom blend. The present disclosure also features methods for treating neurological conditions (e.g., traumatic brain injury or TBI), or symptoms thereof (e.g., anxiety or depression), with a cannabidiol and/or psilocybin, optionally in combination with a mushroom blend. The present disclosure also features compositions and methods of using psilocybin in combination with a neurotransmitter activity modulator for the treatment of neurological conditions (e.g., TBI), or symptoms thereof (e.g., anxiety or depression).
    Type: Application
    Filed: November 30, 2021
    Publication date: February 15, 2024
    Inventors: Jeffrey Jewell, Mark Wingertzahn, Daniel Carcillo
  • Compositions and Methods For Treating Migraine
    Publication number: 20240024340
    Abstract: As described below, the present disclosure features compositions containing a cannabidiol (CBD) and/or psilocybin, optionally in combination with a mushroom blend. The present disclosure also features methods for treating or preventing migraine, or symptoms thereof, with a cannabidiol and/or psilocybin, optionally in combination with a mushroom blend. The present disclosure also features compositions and methods of using psilocybin in combination with a neurotransmitter activity modulator for the treatment of neurological conditions (e.g., migraine), or symptoms thereof (e.g., anxiety or depression).
    Type: Application
    Filed: November 30, 2021
    Publication date: January 25, 2024
    Inventors: Jeffrey Jewell, Mark Wingertzahn, Daniel Carcillo
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING VIRAL INFECTIONS
    Publication number: 20230165881
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for treating respiratory viral illnesses, such as COVID-19.
    Type: Application
    Filed: April 29, 2021
    Publication date: June 1, 2023
    Inventors: Jonathan Lawrence, Jeffrey Meisner, Christopher Matthew Liu, Madeline Rosini, Max Hecht, Mark Wingertzahn, Geoffrey A. von Maltzahn